Last update 25 Mar 2025

ANX-007

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Anti-C1q therapy, ANX 007
Target
Action
inhibitors
Mechanism
C1q inhibitors(Complement C1q subcomponent inhibitors)
Inactive Indication
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
RegulationFast Track (United States), PRIME (European Union)
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Age Related Macular DegenerationPhase 3
United States
30 Jul 2024
Age Related Macular DegenerationPhase 3
Australia
30 Jul 2024
Age Related Macular DegenerationPhase 3
Canada
30 Jul 2024
Age Related Macular DegenerationPhase 3
New Zealand
30 Jul 2024
Age Related Macular DegenerationPhase 3
Spain
30 Jul 2024
Age Related Macular DegenerationPhase 3
United Kingdom
30 Jul 2024
Geographic AtrophyPhase 3
United States
30 Jul 2024
Geographic AtrophyPhase 3
Australia
30 Jul 2024
Geographic AtrophyPhase 3
Canada
30 Jul 2024
Geographic AtrophyPhase 3
New Zealand
30 Jul 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
270
ANX 007 5mg monthly (EM)
mchaqzoosh(riialnclmg) = wkcpblpuqw rdylcinuhw (sohhpjhtle )
Positive
13 Feb 2025
ANX007 5mg every other month (EOM)
mchaqzoosh(riialnclmg) = mjzbqyqnir rdylcinuhw (sohhpjhtle )
Phase 2
270
cbvnljujoi(imppsjwhqg) = plnvvohmla mxilmpdwcl (mxirvedazk )
Positive
21 Oct 2024
Sham
cbvnljujoi(imppsjwhqg) = hmhhlmmzis mxilmpdwcl (mxirvedazk )
Not Applicable
-
-
ANX007 5 mg monthly
xteloianyo(ajzzipnhja) = gocnhjtlsz abndatzihf (sbrrdeownd )
-
19 Sep 2024
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free